News & Articles
Selected Filters:
How to revolutionize your immunoassay development with SpyTag antibodies
Watch this on demand webinar to learn about SpyTag-SpyCatcher technology and how TrailBlazer Antibodies can transform your assay development
AstraZeneca’s COVID-19 vaccine authorized for emergency supply in the UK
Working with the UK government, first vaccinations are to begin early in the new year
Seegene’s COVID-19/FluA,B/RSV test with extraction-free feature now available in Europe
The real-time RT-PCR assay can simultaneously detect and differentiate 8 target genes, the first and only test to do so in the world
Catch highlights from the Virtual Biopharmaceutical Summit 2020
Top talks and resources exploring the latest research and methods in the field are now available on demand
Protecting chocolate supplies: Scientists devise biosensor tests to tackle cocoa disease blighting West Africa
Dr. Jacqueline Barnett and Dr. Joel Allainguillaume discuss their work to develop handheld detectors to combat the spread of cacao swollen shoot virus and arrest the decline in the cocoa industry
Roche receives FDA authorization for semi-quantitative test to measure the level of SARS-CoV-2 antibodies
Elecsys Anti-SARS-CoV-2 S test specifically detects antibodies against the SARS- CoV-2 spike protein
Investigating traditional and modern approaches to antimicrobial susceptibility testing
Explore ways to improve time to result in critical pathways such as sepsis
Pfizer/BioNTech’s COVID-19 vaccine gets a major endorsement from FDA committee
In a 17-4 vote, the FDA vaccine advisory committee recommended that Pfizer/BioNTech’s COVID-19 vaccine should be distributed to the U.S.
All antibodies are not created equal: Comprehensive profiling of SARS-CoV-2 antibodies
Watch this on-demand webinar to learn how COVID immune responses can be assessed using a novel microfluidic in-solution immunoassay platform
Beckman Coulter launches its semi-quantitative SARS-CoV-2 IgG II antibody test
Access SARS-CoV-2 IgG II test is a semi-quantitative assay that measures patient’s relative level of antibodies in response to a previous SARS-CoV-2 infection
Oxford University breakthrough on global COVID-19 vaccine
Phase 3 interim analysis including 131 Covid-19 cases indicates that the vaccine is 70.4% effective when combining data from two dosing regimens
AstraZeneca COVID-19 vaccine AZD1222 met primary efficacy endpoint
Two different dosing regimens demonstrated efficacy with one showing a better profile
The University of Oxford and Thermo Fisher Scientific ramp up COVID-19 testing capability
The collaboration aims to secure manufacturing and testing capacity in the next phase of the pandemic
Siemens Healthineers is the first leading diagnostics company offering a quantitative COVID-19 test to measure neutralizing antibodies
As SARS-CoV-2 vaccines become available, Siemens Healthineers is ready with fully automated antibody tests that can be used to help inform whether broad vaccination programs are working
QIAGEN launches NeuMoDx multiplex test to complete range of SARS-CoV-2 testing solutions in Europe and other markets
Test adds to QIAGEN’s growing portfolio of PCR testing solutions for COVID-19 testing
World-class speaker lineup announced for Virtual Biopharmaceutical Summit 2020
Join scientists from across the globe to explore the latest developments in biopharma, from new research techniques to cutting-edge technologies and resources to advance your work
QIAGEN launches portable digital SARS-CoV-2 antigen test that can accurately analyze over 30 samples per hour
QIAreach SARS-CoV-2 Antigen Test is an important step towards decentralized mass screening by processing samples in 2–15 minutes























